NDC 66215-718
Uptravi 1800 ug per 10 mL injection, powder, for solution
On the label: Actelion Pharmaceuticals US, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Almac Sciences Limited | Craigavon, United Kingdom | Makes the active ingredient and tests it | No problems foundMay 8, 2025 · 5 inspections |
| Eurofins Amatsigroup Sas | Idron, France | Makes it | Problems found, fixed voluntarilyJul 12, 2024 · 2 inspections |
| Konapharma AG | Pratteln, Switzerland | Makes it | Problems found, fixed voluntarilyJun 19, 2024 · 5 inspections |
| Almac Pharma Services Limited | Craigavon, United Kingdom | Tests it | Problems found, fixed voluntarilyNov 28, 2025 · 8 inspections |
| Eurofins Amatsi Analytics | Fontenilles, France | Tests it | Problems found, fixed voluntarilyMay 20, 2026 · 5 inspections |
| Solvias France | Hombourg, France | Tests it | Problems found, fixed voluntarilySep 23, 2022 · 3 inspections |
| Wickham Micro Limited | Gosport, United Kingdom | Tests it | Problems found, fixed voluntarilyFeb 2, 2023 · 5 inspections |
Product details
- Generic drug
- Selexipag: every company that makes it
- Form
- injection, powder, for solution, intravenous
- Strength
- 1800 ug per 10 mL
- Approval
- NDA NDA214275
- On the market since
- Jul 29, 2021
- Package NDCs
66215-718-01- Official label
- DailyMed (National Library of Medicine), updated May 28, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?